Pharmalot By Ed Silverman Which drug makers do a good job getting poor patients access to their medicines?
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Battle over California’s Prop 61 for lower drug prices is tightening
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Americans say lowering drug costs is a top priority
Pharmalot By Ed Silverman Are concerns about a price war between Johnson & Johnson and Pfizer ‘overblown’?
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Did Abbott rep in India kill himself over sales goals?
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Pharma faces challenges as AIDS patients live longer
Pharmalot By Ed Silverman J&J must pay $70 million to male teen who took Risperdal and developed large breasts
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Investors tell pharma to ‘take control’ of the pricing debate
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Johnson & Johnson to pay $498M over hip implant injuries